Live feed
Filing
SC 13G/A
SC 13G/A0000932471-17-001275·KERYX BIOPHARMACEUTICALS INC
Schedule 13G ownership disclosure
KERYX BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 492515101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-17-001275
- Form type
- SC 13G/A
- Filer
- KERYX BIOPHARMACEUTICALS INC
- CIK
- CIK 1114220
- Filed
- Feb 10, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership